While the impact of the IRA on our business and the pharmaceutical industry cannot yet be fully determined, it is likely to be significant.
All entries for: AN2 Therapeutics
August 12, 2025
AN2 Therapeutics
Negative Outlook
Menlo Park, CA
1-50 employees
The Trump administration has also issued executive orders that address the pricing of pharmaceuticals in the U.S. and propose a so-called most favored nation pricing policy, which would tie the price of drugs in the U.S. to the lowest price in a group of other countries. While it is unclear whether and how the Trump proposals will be implemented, the Trump policies are likely to have a negative impact on the pharmaceutical industry. Even proposals or executive actions that are ultimately deemed unlawful could negatively impact the U.S. pharmaceutical sector and our business.
May 13, 2025
AN2 Therapeutics
Negative Outlook
Menlo Park, CA
1-50 employees
It is currently unclear how the IRA will be implemented but is likely to have a significant impact on the pharmaceutical industry. We expect that additional U.S. federal healthcare reform measures will be adopted in the future, any of which could limit the amounts that the U.S. federal government will pay for healthcare products and services, which could result in reduced demand for our product candidates or additional pricing pressures.
Disease Area: Infectious Diseases, Multiple, Oncology, Respiratory Diseases
Drug Type: Small Molecule